Fig. 3

Topographical distributions of the spinal cord lesions in patients with NMOSD according to EDSS classification and anti-AQP4 antibody status. a. Most of the spinal cord lesions were located at the middle cervical levels. The poor outcome group had more T3-T5 vertebral body lesions than the good outcome group; the groups were defined by three-month EDSS scores (> 4: poor outcome group; < 4: good outcome group). b. The serum anti-AQP4 antibody-positive group had more C1-C5 vertebral body lesions than the serum anti-AQP4 antibody-negative group, while the serum anti-AQP4 antibody-negative group had more upper thoracic vertebral body lesions than the serum anti-AQP4 antibody-positive group